As drug overdoses continue to rise in the United States, doctors and policymakers search for solutions to stem the tide of opioid-related deaths. Researchers at NewYork-Presbyterian/Weill Cornell are studying the efficacy of statewide online databases to track prescriptions.

In a quest to better define depression diagnosis, a neuroscientist and psychiatrist at NewYork-Presbyterian/Weill Cornell used fMRI brain scans to identify unique subtypes of depression.

Dr. Mann and his Columbia colleagues have been investigating the use of ketamine as a treatment option for rapidly reducing suicidal thoughts in patients with refractory depression.

A workgroup of experts in borderline personality disorder in the Department of Psychiatry at NewYork-Presbyterian/Columbia and NewYork-Presbyterian/Weill Cornell has published a literature review and a direction for future research in BPD.

A $4 million, 4-year grant from the National Institute of Mental Health (NIMH) enabled Weill Cornell Medicine investigators to found the Advanced Laboratory for Accelerating the Reach and Impact of Treatments for Mid- and Late-Life Depression (ALACRITY) Research Center.

Suicide rates have been rising in nearly every state, and in 2016, nearly 45,000 Americans died by suicide according to the Centers for Disease Control and Prevention.

During his tenure, Jack D. Barchas integrated the Manhattan and Westchester campuses, thereby advancing the excellence of both programs and establishing a comprehensive and nationally recognized psychiatric program.

Francis S. Lee, a leading physician-scientist whose research focuses on anxiety disorders, succeeds Jack D. Barchas, MD, an early mentor of Dr. Lee who has served as chair of the department for 25 years and remains on faculty.